ID | 1080 |
Name of the vaccine | DT Polio Adsorbed |
Microbe | Bacteria |
Disease name | Tetanus (Lock Jaw) |
Name of bacteria | Clostridium tetani |
Type of vaccine | Combination |
Nucleic acid content | DNA |
Age | 7 years and older |
Description of the vaccine | Diphtheria, tetanus and inactivated poliovirus vaccine. |
Name of the manufacturer | Sanofi Pasteur Ltd |
Name of the manufacturing country | Canada |
Year of manufacture | NA |
Clinical Phase status | Approved |
Bacterial strain | An obligate anaerobic bacillus, which is gram positive. |
Efficacy | 100% seroprotection rate. |
Vaccine formulation | Suspension for injection |
Dosage | Given as a second booster. |
Mechanism of action | Threshold of 1.0 IU/mL. |
Route of administration | Intramuscular |
Indications | NA |
Export | NA |
Approval | NA |
Adjuvant | Aluminium phosphate |
Repurposing | For diphtheria and inactivated poliovirus. |
Side effects of vaccine | Erythema, pain and swelling. |
Post vaccination | NA |
Dose type | Single dose |
Interspecies transfer | NA |
PubMed identifier | 21441781 |
Clinical trial number | NA |
Reference | http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=563&keywords= |
Other name | NA |
Additional Links | NA
|